Bisphenol AF
| BPAF | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 336.23 g/mol [1] |
| Appearance | White to light gray powder [1] |
| Density | 1.447 gm/cu cm[NTP; Chemical Information Profile for Bisphenol AF [1] |
| Melting point | 159- 162 °C [1] |
| Boiling point | 400 °C[NTP; Chemical Information Profile for Bisphenol AF [1] |
| Decomposition | When heated to decomposition it emits toxic vapors of fluorine [1] |
| Solubility | Solubility in water: Negligible [1] |
| Predicted LogP | 4.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C15H10F6O2 |
| IUPAC name | 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenol |
| SMILES | C1=CC(=CC=C1C(C2=CC=C(C=C2)O)(C(F)(F)F)C(F)(F)F)O |
| InChI | InChI=1S/C15H10F6O2/c16-14(17,18)13(15(19,20)21,9-1-5-11(22)6-2-9)10-3-7-12(23)8-4-10/h1-8,22-23H |
| InChIKey | ZFVMWEVVKGLCIJ-UHFFFAOYSA-N |
| CAS number | 1478-61-1 |
| UNII | OH7IX8A37J |
| PubChem CID | 73864 |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - oral: 3400 mg/kg [1] |
Bisphenol AF (also known as 2,2-Bis(4-hydroxyphenyl)hexafluoropropane, Hexafluorobisphenol a, 4,4'-(Hexafluoroisopropylidene)diphenol, Biphenol AF, Hexafluorodiphenylolpropane, 2,2-Bis(4-hydroxyphenyl)perfluoropropane, Hexafluoroacetone bisphenol A, Hexafluoroisopropylidenebis(4-hydroxybenzene), 2,2-Bis-(p-hydroxyphenyl)-hexafluoropropane or 4,4'-(1,1,1,3,3,3-Hexafluoropropane-2,2-diyl)diphenol) is a estrogen and xenoestrogen substance of the phenol class.
Chemistry
Stereochemistry []
Bisphenol AF is achiral.
Druglikeness
Lipinski's rule of five
Bisphenol AF matches Lipinski's rule of five.Pharmacology
MeSH Classification
- endocrine disruptors (M0483842)
Mechanism of action []
Endocrine-disrupting chemicals (EDCs) are widely found in the environment. Estrogen-like activity is attributed to EDCs, such as bisphenol A (BPA), bisphenol AF (BPAF), and zearalenone (Zea), but mechanisms of action and diversity of effects are poorly understood. /The researchers/ used in vitro models to evaluate the mechanistic actions of BPA, BPAF, and Zea on estrogen receptor (ER) alpha and ERbeta. /The researchers/ used three human cell lines (Ishikawa, HeLa, and HepG2) representing three cell types to evaluate the estrogen promoter activity of BPA, BPAF, and Zea on ERalpha and ERbeta. Ishikawa/ERa stable cells were used to determine changes in estrogen response element (ERE)-mediated target gene expression or rapid action-mediated effects. The three EDCs showed strong estrogenic activity as agonists for ERalpha in a dose-dependent manner. At lower concentrations, BPA acted as an antagonist for ERalpha in Ishikawa cells and BPAF acted as an antagonist for ERbeta in HeLa cells, whereas Zea was only a partial antagonist for ERalpha. ERE-mediated activation by BPA and BPAF was via the AF-2 function of ERalpha, but Zea activated via both the AF-1 and AF-2 functions. Endogenous ERalpha target genes and rapid signaling via the p44/42 MAPK pathway were activated by BPA, BPAF, and Zea. BPA and BPAF can function as EDCs by acting as cell type-specific agonists (= 10 nM) or antagonists (= 10 nM) for ERalpha and ERbeta. Zea had strong estrogenic activity and activated both the AF-1 and AF-2 functions of ERalpha. In addition, all three compounds induced the rapid action-mediated response for ERalpha. [1]
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 73864, Bisphenol AF. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/73864
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Bisphenol AF. UNII: OH7IX8A37J. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/OH7IX8A37J
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 20:00:47 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 20:00:43 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 20:00:43 |
| gsrs | ok | 2026-11-20 20:00:43 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0249276) | 2026-11-20 20:00:43 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 20:00:47 |
| pubchem | ok | 2026-11-20 20:00:43 |
| missing (no r/tripreports posts mention it) | 2026-11-20 20:00:43 | |
| sider | missing (not in SIDER) | 2026-11-20 20:00:43 |
| structure | ok | 2026-11-20 20:00:43 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 20:00:43 |